DK1041997T3 - Use of citrullinated peptides derived from filaggrin for the treatment of autoimmune diseases - Google Patents

Use of citrullinated peptides derived from filaggrin for the treatment of autoimmune diseases

Info

Publication number
DK1041997T3
DK1041997T3 DK98964537T DK98964537T DK1041997T3 DK 1041997 T3 DK1041997 T3 DK 1041997T3 DK 98964537 T DK98964537 T DK 98964537T DK 98964537 T DK98964537 T DK 98964537T DK 1041997 T3 DK1041997 T3 DK 1041997T3
Authority
DK
Denmark
Prior art keywords
filaggrin
treatment
autoimmune diseases
peptides derived
citrullinated peptides
Prior art date
Application number
DK98964537T
Other languages
Danish (da)
Inventor
Guy Serre
Elisabeth Girbal-Neuhauser
Christian Vincent
Michel Simon
Mireille Sebbag
Pascal Dalbon
Colette Jolivet-Reynaud
Michel Arnaud
Michel Jolivet
Original Assignee
Univ Toulouse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Toulouse filed Critical Univ Toulouse
Application granted granted Critical
Publication of DK1041997T3 publication Critical patent/DK1041997T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention concerns the use of a citrulline peptide antigen derived from filaggrin to obtain medicines for treating rheumatoid arthritis.
DK98964537T 1997-12-30 1998-12-29 Use of citrullinated peptides derived from filaggrin for the treatment of autoimmune diseases DK1041997T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9716672A FR2773078B1 (en) 1997-12-30 1997-12-30 USE OF CITRULLIN PEPTIDES DERIVED FROM FILAGGRIN FOR THE TREATMENT OF RHUMATOID POLYARTHRITIS
PCT/FR1998/002900 WO1999034819A2 (en) 1997-12-30 1998-12-29 Use of citrulline peptides derived from filaggrin for treating autoimmune diseases

Publications (1)

Publication Number Publication Date
DK1041997T3 true DK1041997T3 (en) 2003-08-04

Family

ID=9515271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98964537T DK1041997T3 (en) 1997-12-30 1998-12-29 Use of citrullinated peptides derived from filaggrin for the treatment of autoimmune diseases

Country Status (10)

Country Link
EP (1) EP1041997B1 (en)
JP (1) JP4557421B2 (en)
AT (1) ATE237345T1 (en)
AU (1) AU1971899A (en)
CA (1) CA2315294C (en)
DE (1) DE69813620T2 (en)
DK (1) DK1041997T3 (en)
ES (1) ES2193601T3 (en)
FR (1) FR2773078B1 (en)
WO (1) WO1999034819A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900657B1 (en) * 2006-05-03 2009-04-17 Univ Toulouse IDENTIFICATION OF MACROPHAGE ACTIVATION MODULATORS, USEFUL FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
FR2908134B1 (en) * 2007-12-04 2012-10-12 Univ Toulouse 3 Paul Sabatier IDENTIFICATION OF MACROPHAGE ACTIVATION MODULATORS, USEFUL FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3307636B2 (en) * 1990-01-31 2002-07-24 ボード オブ リージェンツ オブ ザ ユニバーシティ オブ オクラホマ Assays and treatments for autoimmune diseases
CA2084876A1 (en) * 1991-04-26 1992-10-27 Guy Serre Antigens specifically recognized by specific antibodies of rheumatoid arthritis, their constituent proteins, preparation and applications
AU6098994A (en) * 1993-01-27 1994-08-15 Duke University Methods and agents for the diagnosis and treatment of rheumatoid arthritis
FR2752842B1 (en) * 1996-08-30 1998-11-06 Biomerieux Sa ANTIGENS DERIVED FROM FILAGGRINS AND THEIR USE FOR THE DIAGNOSIS OF RHUMATOID POLYARTHRITIS
NL1004539C2 (en) * 1996-11-15 1998-05-20 Stichting Tech Wetenschapp Peptide derived from an antigen recognized by autoantibodies of patients with rheumatoid arthritis, antibody to it and method for detecting autoimmune antibodies.
WO1999028344A2 (en) * 1997-11-28 1999-06-10 Innogenetics N.V. Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
FR2773157B1 (en) * 1997-12-30 2001-10-05 Bio Merieux PEPTIDE EPITOPES RECOGNIZED BY ANTIFILAGGRIN AUTOANTIBODIES PRESENT IN THE SERUM OF PATIENTS WITH RHUMATOID POLYARTHRITIS

Also Published As

Publication number Publication date
ES2193601T3 (en) 2003-11-01
DE69813620D1 (en) 2003-05-22
AU1971899A (en) 1999-07-26
FR2773078B1 (en) 2000-05-26
FR2773078A1 (en) 1999-07-02
DE69813620T2 (en) 2004-02-12
WO1999034819A2 (en) 1999-07-15
CA2315294C (en) 2012-07-03
JP4557421B2 (en) 2010-10-06
JP2002500195A (en) 2002-01-08
ATE237345T1 (en) 2003-05-15
CA2315294A1 (en) 1999-07-15
EP1041997B1 (en) 2003-04-16
EP1041997A2 (en) 2000-10-11
WO1999034819A3 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
HUP0204199A2 (en) Transport vectors
ATE348632T1 (en) PRION PROTEIN PEPTIDES AND THEIR USE
MX9704897A (en) Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen.
BR9707819A (en) Peptide immunogens
DE69414471T2 (en) Sealing arrangement for the introduction of surgical instruments
ATE193839T1 (en) PURIFICATION OF PROTEINS
ES2092998T3 (en) POLYPEPTIDES THAT HAVE ACTIVITY OF TYROTROPINE RECEPTORS, NUCLEIC ACID SEQUENCES THAT CODE FOR SUCH RECEPTORS AND POLYPEPTIDES, AND APPLICATIONS OF THESE POLYPEPTIDES.
TR200103396T2 (en) Pharmaceutical compositions containing anti-fas antibody.
AR002742A1 (en) ADIPOSE TYPE REGULATORY PROTEIN, PROCEDURE TO PRODUCE SUCH PROTEIN, PHARMACEUTICAL FORMULATIONS INCLUDING IT, ISOLATED DNA MOLECULES THAT CODES SUCH PROTEIN, VECTOR AND RECOMBINANT CELLS THAT INCLUDE SUCH DNA
DK1042228T3 (en) Process for the treatment of cement sludge
DE69807466D1 (en) TRIPTOLID DERIVATIVES USEFUL FOR THE TREATMENT OF AUTOIMMUNE DISEASES
PT840620E (en) IL-8 ANTAGONISTS FOR ASTHMA TREATMENT
DK1041997T3 (en) Use of citrullinated peptides derived from filaggrin for the treatment of autoimmune diseases
FR2692282B1 (en) CLONING OF THE GENE ENCODING THE PROTEIN GP28.5 OF T. GONDII; PEPTIDE FRAGMENTS FROM SUCH PROTEIN AND THEIR APPLICATIONS.
TR199800517A2 (en) Hémanize anti-hémen fas antikor.
NL1007401A1 (en) Waste gas treatment facility.
DK1021200T3 (en) Methods and Preparations for the Treatment of Rheumatoid Arthritis
BR9812368A (en) 2-aminotetralins, process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and / or autoimmune pathologies
DE69738600D1 (en) NEUROACTIVE PEPTIDES
DE69632535D1 (en) PEPTIDES FOR DETECTING HIV-1
DK0833842T3 (en) New peptides for use in the treatment of T-cell mediated cartilage degradation in autoimmune diseases
ATE356144T1 (en) EZRIN REGULATORY/DEVELOPING PEPTIDES
BR9811250A (en) Peptides comprising a t cell epitope, specifically for collagen ii
NO974852L (en) Human <beta> 2-integrin <alfa> subunit
ES2158235T3 (en) ANTIGENIC PEPTIDES WITH SUBSTITUTIONS OF GLYCINE.